Voyager Therapeutics, Inc. Common Stock (VYGR) — Analysis Summary
Voyager Therapeutics, Inc. Common Stock (VYGR) has a market cap of $233.83M with year-over-year revenue growth of -49.5%. Net margin stands at -296.5%. The stock trades at a P/E ratio of -2.0.
Key Takeaways
- Revenue changed -49.5% year-over-year
- Net margin of -296.5%
- P/E ratio of -2.0
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, VYGR posted revenue growth of -49.5% and trades at a P/E of -2.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.